Robin Sherrington Insider Trades

Insider Trading History

Track insider trading activity for Robin Sherrington. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Evp, Strategy & Innovation
Holding Value $3.44M 65,000 shares
Last Trade
Mar 11, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.88M 65,000 shares
$44.37
$52.99
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Evp, Strategy & Innovation
Holding Value $823k 15,535 shares
Last Trade
Mar 07, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$69.1k 1,504 shares
$45.96
$52.99
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Evp, Strategy & Innovation
Holding Value $769k 14,516 shares
Last Trade
Mar 07, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$330k 7,137 shares
$46.28
$52.99
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Evp, Strategy & Innovation
Holding Value $892k 16,824 shares
Last Trade
Mar 07, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$399k 8,641 shares
$46.16
$52.99
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Evp, Strategy & Innovation
Holding Value $0 0 shares
Last Trade
Mar 07, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$342k 7,407 shares
$46.16
$52.99
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Evp, Strategy & Innovation
Holding Value $445k 8,398 shares
Last Trade
Dec 29, 2023 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$387k 8,398 shares
$46.06
$52.99
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Evp, Strategy & Innovation
Holding Value $3.97M 75,000 shares
Last Trade
Mar 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.56M 75,000 shares
$34.18
$52.99
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Evp, Strategy & Innovation
Holding Value $1.36M 25,572 shares
Last Trade
Sep 01, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.33M 35,103 shares
$38.03
$52.99
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Evp, Strategy & Innovation
Holding Value $0 0 shares
Last Trade
Sep 01, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.98M 50,000 shares
$39.53
$52.99
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Evp, Strategy & Innovation
Holding Value $0 0 shares
Last Trade
Aug 31, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$679k 17,488 shares
$38.81
$52.99
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Evp, Strategy & Innovation
Holding Value $0 0 shares
Last Trade
Aug 31, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$194k 5,000 shares
$38.81
$52.99
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Evp, Strategy & Innovation
Holding Value $890k 16,796 shares
Last Trade
Aug 31, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$824k 21,352 shares
$38.57
$52.99
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Evp, Strategy & Innovation
Holding Value $3.22M 60,675 shares
Last Trade
Aug 31, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$238k 6,121 shares
$38.81
$52.99
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Evp, Strategy & Innovation
Holding Value $890k 16,796 shares
Last Trade
Aug 31, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$341k 8,776 shares
$38.80
$52.99
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Evp, Strategy & Innovation
Holding Value $1.84M 34,720 shares
Last Trade
Aug 31, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$679k 17,488 shares
$38.81
$52.99
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Evp, Strategy & Innovation
Holding Value $3.54M 66,796 shares
Last Trade
Aug 31, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.94M 50,000 shares
$38.81
$52.99
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Evp, Strategy & Innovation
Holding Value $2.02M 38,148 shares
Last Trade
Aug 31, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$59.5k 1,572 shares
$37.86
$52.99
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Evp, Strategy & Innovation
Holding Value $2.1M 39,720 shares
Last Trade
Aug 31, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$194k 5,000 shares
$38.81
$52.99
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Evp, Strategy & Innovation
Holding Value $3.97M 75,000 shares
Last Trade
Mar 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.25M 75,000 shares
$30.01
$52.99
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Evp, Strategy & Innovation
Holding Value $3.97M 75,000 shares
Last Trade
Mar 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.25M 75,000 shares
$30.01
$52.99

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up